Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alfacell Corporation
Biopharmaceutical firm appoints new chief financial officer
June 22nd, 2005
Alfacell Corporation (ACEL) appointed Robert D. Love, CPA, MBA, to the position of chief financial officer, effective immediately. Love succeeds Andrew Savadelis, who is leaving the company to pursue other business opportunities. "We thank Andrew Savadelis for his contributions, and wish him well in his new endeavors," stated Kuslima Shogen, CEO of Alfacell. "We are also very pleased to welcome Bob Love to our management team. Bob is a highly accomplished, senior-level executive in the pharmaceutical industry. His proven track record and extensive experience in high-profile leadership positions across several disciplines will prove invaluable to our continuing efforts...
Source: Physician Law Weekly (2005-06-22)
|
